|

AGuIX gadolinium-based nanoparticles Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Dana-Farber Cancer Institute1

Indications

  • Cystic1
  • Nanoparticle1
  • AGuIX1
  • Whole Brain Radiation1
  • SRT1

Boston, Massachusetts1 trial

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Brigham and Women's Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.